{
    "code": "72000015",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=72000015",
    "time": "2022-10-21 03:48:21",
    "許可證字號": "衛部罕菌疫輸字第000015號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/12\/27",
    "發證日期": "102\/12\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA07200001504",
    "中文品名": "雪瑞素 400U",
    "英文品名": "Cerezyme 400U",
    "適應症": "1. 第一型高雪氏症:\r\nCerezyme(Imiglucerase凍晶注射劑)用於需要長期酵素替代療法，並經診斷確認為第一型高雪氏症且併發下列症狀之兒童或成人病患:\r\na. 貧血 b. 血小板減少症 c. 骨病變 d. 肝臟腫大或脾臟腫大\r\n2. 第三型高雪氏症:\r\n改善高雪氏症症狀，包括貧血、血小板減少症、肝臟或脾臟腫大、骨病變，但對於神經學症狀無效。",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "IMIGLUCERASE",
    "限制項目": "02輸　入 26監視期滿新藥",
    "申請商名稱": "1707201200  賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIE0035000  GENZYME IRELAND LIMITED",
            "製造廠廠址": "IDA INDUSTRIAL PARK, OLD KILMEADEN ROAD, WATERFORD, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FUS0348200  RESILIENCE US, INC.",
            "製造廠廠址": "500 SOLDIERS FIELD RD, ALLSTON, MA 02134, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FUS0508000  LONZA BIOLOGICS, INC.",
            "製造廠廠址": "101 INTERNATIONAL DRIVE PEASE INTERNATIONAL TRADEPORT PORTSMOUTH, NEW HAMPSHIRE, U.S. 03801",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FUS0788000  Genzyme Corporation",
            "製造廠廠址": "11 Forbes Road, Northborough, MA 01532, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200099000",
            "成分名稱": "IMIGLUCERASE",
            "含量描述": "",
            "含量": "424.0000000000",
            "單位": "U (UNIT)"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Cerezyme - Vial Photo-104-09-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000015&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Cerezyme 400_Leaflet_SmPC2013 (Lonza)_678681-107-02-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000015&Seq=004&Type=9"
        },
        {
            "title": "衛部罕菌疫輸字第000015號Chinese PI 20150717-104-07-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000015&Seq=002&Type=9"
        },
        {
            "title": "Cerezyme 400_Box 595132-107-02-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000015&Seq=004&Type=8"
        }
    ]
}